ArticleInvestigational new drugs2020

Impact of neutrophil-to-lymphocyte ratio in patients with EGFR-mutant NSCLC treated with tyrosine kinase inhibitors.

Taihei Ono et al.PubMed ↗Publisher ↗

No numbers read from the abstract.